FOLR1 and ovarian carcinoma: The possibility that circulating tumour cells (CTCs) or tumour cell fragments bearing multiple copies of the target antigen could trigger degranulation was also explored by exposing RBL SX-38 effector cells to MOv18 IgE and serially increasing the number of FRα-expressing IGROV1 ovarian carcinoma cells.